Nektar Therapeutics (Nektar, we) is a clinical stage, research-based drug discovery biopharmaceutical company focused on discovering and developing innovative medicines in the field of immunotherapy. Within this growing field, we direct our efforts toward creating new immunomodulatory agents that selectively induce, amplify, attenuate or prevent immune responses in order to achieve desired therapeutic outcomes. We apply our deep understanding of immunology to identify and create innovative drug ...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-13 | 2025-12-31 | 0001193125-26-104547 | EDGAR | 74K words |
| 2025-03-14 | 2024-12-31 | 0000950170-25-039389 | EDGAR | — |
| 2024-03-05 | 2023-12-31 | 0000950170-24-026249 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000906709-23-000004 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000906709-22-000005 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0000906709-21-000005 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0000906709-20-000004 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001564590-19-005639 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001564590-18-004105 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001564590-17-003064 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001193125-25-270230 | EDGAR | 45K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105275 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0000950170-25-067279 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000950170-24-123570 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0000950170-24-094231 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057312 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-060475 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000906709-23-000012 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000906709-23-000008 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0000906709-22-000019 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0000906709-22-000014 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0000906709-22-000010 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-12 | 0001213900-26-027026 | EDGAR | 4K words |
| 2026-02-13 | 0001193125-26-049378 | EDGAR | — |
| 2026-02-10 | 0001193125-26-044751 | EDGAR | — |
| 2026-02-10 | 0001193125-26-043755 | EDGAR | — |
| 2026-01-27 | 0001213900-26-008210 | EDGAR | — |
| 2025-12-16 | 0001193125-25-320009 | EDGAR | — |
| 2025-11-21 | 0001213900-25-113606 | EDGAR | — |
| 2025-11-10 | 0001213900-25-107821 | EDGAR | — |
| 2025-11-06 | 0001213900-25-107180 | EDGAR | — |
| 2025-09-18 | 0001213900-25-088792 | EDGAR | — |
231 total filings indexed. 199 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000906709 |
| Ticker | NKTR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.nektar.com |
| Listed | 1994-05-03 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NKTR (~200 tokens, structured JSON with cryptographic provenance)